A previous study reports that a serum albumin level <3.7 g/dL was independently associated with poor composite renal outcomes (predialysis mortality and end-stage renal disease) in patients with CKD-ND (31). The gene discussed is ALB; the disease is stage 5 chronic kidney disease.